Drafted and prosecuted a patent portfolio regarding delivery mechanisms for large protein therapeutics for a university, which was licensed by a start-up that was ultimately acquired by an international pharmaceutical company for about $90 million, as well as an antibody therapeutic patent portfolio which was acquired by a large pharmaceutical company for about $235 million.
McCarter & English, LLP | Contents of this website may contain attorney advertising. | Results may vary depending on your particular facts and legal circumstances.